In this insightful discussion, Dr. Alison Cohen, an epidemiologist from UC San Francisco, and Dr. Julia Moore Vogel, a computational biologist at Scripps Research, share their personal journeys with long COVID. They explore the potential of Paxlovid as a treatment, revealing mixed results among patients who extended their usage. The conversation highlights the complex, individualized nature of long COVID symptoms and the urgent need for tailored therapies and further research. Their combined expertise underscores the pressing quest for effective solutions in this evolving health crisis.
